New combo therapy aims to beat tough skin cancers without major surgery
Disease control
Recruiting now
This study is for people with high-risk basal cell skin cancer that is hard to treat with surgery alone. It tests a combination of an immunotherapy drug (cemiplimab), a topical cream (imiquimod), and laser therapy given before surgery to shrink tumors and lower the chance of the …
Phase: PHASE1, PHASE2 • Sponsor: Instituto Oncológico Dr Rosell • Aim: Disease control
Last updated May 06, 2026 16:14 UTC